New drug DW4421 put through interaction test with common antibiotics
NCT ID NCT07382661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial will test how a new drug called DW4421 interacts with two common antibiotics (amoxicillin and clarithromycin) in 36 healthy adults aged 19 to 50. The study measures safety and how the drug levels change when taken together. It does not aim to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DW4421
- What could go wrong
- This is an early phase 1 study in healthy volunteers, not patients. It only measures drug levels and safety, not whether the drug works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection tame high triglycerides?
- Ancient exercise may hold key to stronger muscles in aging adults
- First human tests begin for new drug DW4421
- Plant-Powered study seeks to unlock gut health secrets
- New injection for ulcerative colitis shows early promise, but trial halted
- New oximeter software put to the test in small study